The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

StocksUpdated×3•Originally published 7 May 2026•Updated 8 May 2026•

1 min read

LifeStance Health Stock Surges 20% Driven by Strong Q1 Revenue Growth

Key Facts

1LifeStance Health Group announced that certain stockholders intend to offer 35,000,000 shares of common stock.

2The Company will not receive any proceeds from the offering as all proceeds go to the Selling Stockholders.

LifeStance Health Group shares surged 20% to reach a two-year high following exceptional first-quarter financial results. The company reported a massive 1,900% surge in net income, reaching $14.2 million, which underscores a significant turnaround in operational efficiency. Consequently, management raised its full-year revenue guidance to a range of $1.64 billion to $1.68 billion. This momentum coincides with the pricing of a secondary public offering of 35,000,000 shares at $8.15 per share by existing stockholders. Although the company will not receive proceeds from this SEC-filed sale, the robust organic growth and margin expansion have solidified investor confidence in the mental health services provider. This update confirms LFST's strengthening position within the integrated healthcare sector.

27 days ago

Version History

Version 327 days ago

What changed: Updated the story to include the massive 1,900% surge in net income, the upward revision of full-year revenue guidance, and the stock reaching a two-year high.

Version 227 days ago

What changed: Updated the story to include the pricing of the secondary public offering at $8.15 per share.

Version 127 days ago

What changed: The narrative shifted from secondary offering concerns to a 20% price surge driven by strong Q1 earnings and 21% revenue growth.